Lv52
1218 积分 2025-07-01 加入
Targeting the Keap1/Nrf2 axis in cancer: molecular mechanisms and pharmacological interventions
5天前
已完结
NRF2 activation in cancer and overview of NRF2 small molecule inhibitors
5天前
已完结
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients With COPD in China (PACER-II): A Phase 2, Multicenter, Randomized, Double-Anonymized, Placebo-Controlled Trial
6天前
已关闭
Hepcidin: A potent antimicrobial peptide involved in iron homeostasis
11天前
已完结
Effect of hepcidin antagonists on anemia during inflammatory disorders
11天前
已完结
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
12天前
已完结
New payloads drive next-gen antibody-drug conjugates
14天前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial
19天前
已完结
Fulzerasib plus cetuximab in first-line KRAS(G12C)-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
19天前
已关闭
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
20天前
已完结
皖公网安备34019202002308
